Advertisement PerkinElmer to release new image data storage and analysis system - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

PerkinElmer to release new image data storage and analysis system

PerkinElmer, a global company focused on health and safety of people and the environment, is set to unveil the enhanced Columbus 2.3 Image Data Storage and Analysis System to help in the research of cancer and stem cells, predictive toxicity, neuroscience and developmental biology.

The new improved Columbus 2.3 system is believed to provide faster and more powerful high content analysis-based research applications.

The platform will now help scientists perform their high content analysis on one platform, from image analysis through to secondary analysis, regardless of their high content screening (HCS) instrument.

The secondary analysis capabilities will enable scientists to select small interfering RNA (siRNA) or compounds with desirable inhibition or activation effects, by proving the statistical significance of the observations made at the image analysis stage of a high content screening campaign.

The improved morphology analysis capability of the software is designed to give scientists a better understanding of the effects different treatments have on cell samples, adding to the Columbus system’s existing analysis tools that enable analysis of high content images acquired on any instrument.